Indications and Purposes
| 1 Indications And Usage Xadago Is Indicated As Adjunctive Treatment To Levodopa/carbidopa In Patients With Parkinson's Disease (Pd) Experiencing "off" Episodes. Xadago Is A Monoamine Oxidase Type B (Mao-B) Inhibitor Indicated As Adjunctive Treatment To Levodopa/carbidopa In Patients With Parkinson's Disease (Pd) Experiencing "off" Episodes ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Safinamide Mesylate |
|
ZINC53084692 |